Magnetic theranostics of Lewis lung carcinoma with the complex of gadopentetate dimeglumine and doxorubicin

Authors

  • V. E. Orel National Cancer Institute, Kiev
  • O. Yu. Rykhalskyi National Cancer Institute, Kiev
  • T. S. Golovko National Cancer Institute, Kiev
  • O. V. Ganich National Cancer Institute, Kiev
  • A. V. Romanov National Cancer Institute, Kiev
  • I. V. Orel National Cancer Institute, Kiev
  • A. P. Burlaka R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS of Ukraine, Kiev
  • S. N. Lukin R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the NAS of Ukraine, Kiev
  • E. F. Venger V. E. Lashkaryov Institute of Semiconductor Physics of the NAS of Ukraine, Kiev

DOI:

https://doi.org/10.15407/dopovidi2016.09.134

Keywords:

doxorubicin, electromagnetic field, electron paramagnetic resonance, gadopentetate dimeglumine, Lewis lung carcinoma

Abstract

The antitumor effect of the complex of gadopentetate dimeglumine (GD) and doxorubicin (DR) in mices with Lewis lung carcinoma is studied. It is shown that the breaking ratio of Lewis lung carcinoma growth was greatest for the group of animals treated with the complex of GD and DR and exposured to external local inhomogeneous static magnetic and electromagnetic fields. According to the computer analysis of magnetic resonance images, the administration of the complex and the electromagnetic irradiation (EI) of Lewis lung carcinoma resulted in a reduction of the tumor image area by 11.8 %, as compared to the officinal DR effect. The DR administration to the animals with Lewis lung carcinoma decreased the level of free iron in the mitochondria of tumor cells by 63 %, as compared to control tumors without influence; while the administration of the complex of GD and DR, on the contrary, increased the level of free iron 9 times, and it was increased by 88 % when combined with EI, as compared to the control group.

Downloads

References

Kunjachan S., Ehling J., Storm G. et al. Chem. Rev., 2015, 115: 10907–10937. https://doi.org/10.1021/cr500314d

Golder W. Onkologie, 2004, 27, No 3: 304–309.

Huang C.-H., Tsourkas A. Curr. Top. Med. Chem., 2013, 13, No 4: 411–421. https://doi.org/10.2174/1568026611313040002

Zhu J., Xiong Z., Shen M., Shi X. RSC Adv., 2015, 5: 30286–30296. https://doi.org/10.1039/C5RA01215E

Zhang G., Du R., Zhang L. et al. Adv., Funct. Mater., 2015, 25: 6101–6111, DOI: 10.1002/adfm.201502868. https://doi.org/10.1002/adfm.201502868

Orel V., Shevchenko A., Romanov A. et al. Nanomedicine, 2015, 11, No 1: 47–55.

Tofani S. Curr. Top. Med. Chem., 2015, 15: 572–578. https://doi.org/10.2174/1568026615666150225104217

Emanuel N. M. Kinetics of experimental tumor processes, Moscow: Nauka, 1977 (in Russian).

Gorelik., Segal S., Feldman M. J. Nat. Cancer Inst., 1980, 65: 1257–1264.

Li H., Calder C. A., Cressie N. Geogr. Anal., 2007, 39: 357–375. https://doi.org/10.1111/j.1538-4632.2007.00708.x

Burlaka A. P., Sidorik E. P. Redox-dependent signaling molecules in the mechanisms of tumor processes, Kyiv: Naukova Dumka, 2014 (in Russian).

Burlaka A. P., Kuchmenko O. B., Ganusevich I. I. et al. Reports of National Academy of Sciences of Ukraine, 2012, No 1: 180–186 (in Ukrainian).

Raduchel B., Weinmann H., Muhler A. Encycl. Nucl. Magn. Resonance, 1996, 4: 2166–2172.

Downloads

Published

19.11.2024

How to Cite

Orel, V. E., Rykhalskyi, O. Y., Golovko, T. S., Ganich, O. V., Romanov, A. V., Orel, I. V., Burlaka, A. P., Lukin, S. N., & Venger, E. F. (2024). Magnetic theranostics of Lewis lung carcinoma with the complex of gadopentetate dimeglumine and doxorubicin . Reports of the National Academy of Sciences of Ukraine, (9), 134–142. https://doi.org/10.15407/dopovidi2016.09.134

Issue

No. 9 (2016): Reports of the National Academy of Sciences of Ukraine

Section

Medicine

License

Copyright (c) 2024 Reports of the National Academy of Sciences of Ukraine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.